GlassScriptPhysician profile
Colin Buchanan
NPI 1801066964
$24,714.49
in general payments reported to CMS, 2019-2025
14 companies · $2,163 in 2025
The $2,163 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,753 · 2020: $6,078 · 2021: $3,521 · 2022: $5,206 · 2023: $797 · 2024: $1,196 · 2025: $2,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,156.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,329.54 | 2021-2025 | Catalyft Pl Expandable Interbody System, Unid_pass, Osteocool Rf Ablation System |
| Medtronic USA, INC. | $11,676.86 | 2019-2020 | |
| Globus Medical, INC. | $124.74 | 2021-2023 | Altera |
| Boston Scientific Corporation | $124.69 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Integra Lifesciences Corporation | $115.41 | 2019-2022 | |
| Stryker Corporation | $67.59 | 2021-2022 | |
| Natus Medical Incorporated | $66.86 | 2020 | |
| Centinel Spine, LLC | $57.63 | 2022 | |
| Orthofix Medical, INC. | $38.70 | 2021-2025 | Spinal-Stim |
| Aesculap, INC. | $32.01 | 2020-2022 | |
| Alphatec Spine, INC | $25.16 | 2020 | |
| Cerapedics INC. | $19.21 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Sanara Medtech INC. | $18.89 | 2023 | Celleraterx |
| Spinal Elements, INC. | $17.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Buchanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.